生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | Ketotifen fumarate blocks histamine1 (H1) receptors, stabilizes mast cells, and acts as an eosinophil inhibitor (decreases chemotaxis and activation of eosinophils). Ketotifen was safe and statistically effective in reducing ocular itching and hyperemia associated with allergic conjunctivitis. Ketotifen's rapid onset of action (within 15 minutes) and extended duration of action (at least 8 hours) make it a valuable treatment for allergic conjunctivitis[3]. Ketotifen is an orally active prophylactic agent for the management of bronchial asthma and allergic disorders. Unlike inhaled sodium cromoglycate, ketotifen ameliorates the symptoms of asthma, rhinitis and dermatitis when present together in atopic patients[4]. Subgroups of animals were treated twice daily for one week with or without ketotifen fumarate (5 mg/kg). Ketotifen fumarate attenuated the initiation and progression of gingivitis and reduced the oxidative stress, and inhibited NF-κB and p38 MAPK related with mast cells and macrophages accumulation[5]. In EAO (experimental autoimmune orchitis) model, KF significantly reduced severity of histopathological testicular damage compared to rats in the vehicle group. KF also reduced the number of testicular MC (Mast cells) compared to vehicle group[6]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.35mL 0.47mL 0.24mL |
11.75mL 2.35mL 1.18mL |
23.50mL 4.70mL 2.35mL |
参考文献 |
---|